Not applicableWithdrawnNCT04349111What this trial is testingAn Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"Who this might be right forInvasive Ductal CarcinomaDuctal Carcinoma In Situ Xoft, Inc.
Testing effectiveness (Phase 2)Study completedNCT05900986What this trial is testingLS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast CancerWho this might be right forBreast CancerDCISInvasive Duct Carcinoma of Breast Integro Theranostics 22
Early research (Phase 1)UnknownNCT03749850What this trial is testingImage-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast CancerWho this might be right forMetastatic Breast CancerBreast CancerBreast Neoplasms+5 more UMC Utrecht 12
Early research (Phase 1)Active Not RecruitingNCT02453620What this trial is testingEntinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more National Cancer Institute (NCI) 57
Post-approval studies (Phase 4)Ended earlyNCT05183828What this trial is testingEffect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more University of Washington 62
Testing effectiveness (Phase 2)Study completedNCT02282345What this trial is testingTalazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast CancerWho this might be right forBreast AdenocarcinomaDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+2 more M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT01593020What this trial is testingNeoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2Who this might be right forBreast Cancer M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009044What this trial is testingTopical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastWho this might be right forCancer SurvivorDuctal Breast Carcinoma In SituInvasive Breast Carcinoma Northwestern University 156
Not applicableEnded earlyNCT03137693What this trial is testingPreoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast CancerWho this might be right forBreast CancerBreast Cancer FemaleBreast Adenocarcinoma H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Testing effectiveness (Phase 2)Study completedNCT00182793What this trial is testingCombination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerWho this might be right forBreast Cancer City of Hope Medical Center 32
Large-scale testing (Phase 3)Study completedNCT00438659What this trial is testingMometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in SituWho this might be right forBreast CancerDermatologic ComplicationsRadiation Toxicity+1 more North Central Cancer Treatment Group 176
Testing effectiveness (Phase 2)Ended earlyNCT01891357What this trial is testingPhase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast CancerWho this might be right forCarcinoma, Ductal, Breast Women's Cancer Study Group GmbH 64
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00354640What this trial is testingSimvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast CancerWho this might be right forBreast Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Very early researchEnded earlyNCT01138553What this trial is testingPreoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast CancerWho this might be right forInvasive Breast CancerDuctal Carcinoma in Situ University of California, San Diego 4
Not applicableLooking for participantsNCT06903468What this trial is testingNovel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisionsWho this might be right forDuctal Carcinoma in SituBreast Cancer University of Florida 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05591547What this trial is testingEvaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation RegimenWho this might be right forBreast Cancer Sanford Health 91
Early research (Phase 1)Study completedNCT04481113What this trial is testingAbemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more OHSU Knight Cancer Institute 8
Testing effectiveness (Phase 2)Looking for participantsNCT07483307What this trial is testingThe Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerWho this might be right forBreast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more Memorial Sloan Kettering Cancer Center 176